MedPath
HSA Approval

ALNIX TABLET 10mg

SIN15298P

ALNIX TABLET 10mg

ALNIX TABLET 10mg

July 14, 2017

FAR EAST DRUG COMPANY (PRIVATE) LIMITED

FAR EAST DRUG COMPANY (PRIVATE) LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFAR EAST DRUG COMPANY (PRIVATE) LIMITED
Licence HolderFAR EAST DRUG COMPANY (PRIVATE) LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AE07

cetirizine

Manufacturer Information

FAR EAST DRUG COMPANY (PRIVATE) LIMITED

Amherst Laboratories, Inc

Active Ingredients

Cetirizine Dihydrochloride

10mg

Cetirizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALNIX TABLET 10mg - HSA Approval | MedPath